IPO registrations (S-1, F-1) · Registrants
Black Hawk Acquisition Corp
- SEC CIK
- 2000775 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2024-02-05, last 2024-03-08; 1 initial registration, 2 amendments
- Outcome
- Final prospectus filed 2024-03-22; declared effective 2024-03-20
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Business address
- 4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, Danville, CA 94506
- Ticker
- BKHA, BKHAR, BKHAU (Nasdaq, Nasdaq, Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Black Hawk Acquisition Corp on the corporate pages
Offering terms
- Final price
- $10.00 per share (424B4 filed 2024-03-22, an initial public offering)
- Shares sold
- 6,900,000
- Gross proceeds
- $69,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol BKHA
- Lead underwriters
- EF Hutton
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- SEC filer: Black Hawk Acquisition Corp EXACT (CIK (EXACT))
Filings 6
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2024-02-05 | S-1 | S-1 (registration) | Black Hawk Acquisition Corp | 0001829126-24-000712 ↗ |
| 2024-02-26 | S-1/A | S-1/A (amendment) | Black Hawk Acquisition Corp | 0001829126-24-001093 ↗ |
| 2024-03-08 | S-1/A | S-1/A (amendment) | Black Hawk Acquisition Corp | 0001829126-24-001492 ↗ |
| 2024-03-20 | S-1MEF | S-1MEF (added securities) | Black Hawk Acquisition Corp | 0001829126-24-001744 ↗ |
| 2024-03-20 | EFFECT | EFFECT (declared effective) | Black Hawk Acquisition Corp | 9999999995-24-000691 ↗ |
| 2024-03-22 | 424B4 | 424B4 (final prospectus) | Black Hawk Acquisition Corp | 0001829126-24-001784 ↗ |
Prospectus pages read 3
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-26 | S-1/A | registration statement | $10.00 | 6,000,000 | $60,000,000 | Nasdaq BKHA | 1 | primary document; price sentence, shares headline, proceeds table, cover names 1 | document ↗ | |
| 2024-03-08 | S-1/A | registration statement | - | - | 0 | primary document; no terms found | document ↗ | |||
| 2024-03-22 | 424B4 | final prospectus | $10.00 | 6,900,000 | $69,000,000 | Nasdaq BKHA | 1 | primary document; price sentence, shares headline, proceeds table, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Black Hawk Management LLC | TenPercentOwner | 2 | 2024 | ||
| Kaufman Kent Louis | Director,Officer | Chairman, CEO, and CFO | 1 | 2024 | |
| McCabe Daniel M. | Director | 1 | 2024 | ||
| Miller Brandon | Director | 1 | 2024 | ||
| Protto Terry William | Director | 1 | 2024 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| IPO registrant | NP Life Sciences Health Industry Group Inc. | CA | IPO registrations (S-1, F-1) | same street address and ZIP code, 4125 BLACKHAWK PLAZA CIR STE 166 94506 (FUZZY: a shared address, not proof of a shared organization) |
| SEC filer | Black Hawk Acquisition Corp | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), CA first:
- SANGAMO THERAPEUTICS, INC CA
- GENITOPE CORP CA
- ABGENIX INC CA
- COLLATERAL THERAPEUTICS INC CA
- Life Technologies Corp CA
- DRUGABUSE SCIENCES INC CA
- STRATAGENE CORP CA
- Cordex Pharma, Inc. CA
- COTHERIX INC CA
- Cardiff Oncology, Inc. CA
In other datasets, the same topic (Health) in CA:
- Nonprofit: 24 HOUR CANCER DANCE-A-THON (Nonprofits (IRS Form 990))
Interests: Biological Products, (No Diagnostic Substances) · Health